.
MergerLinks Header Logo

Announced

Completed

Dechra completed the acquisition of Med-Pharmex from DW Healthcare Partners for $260m.

Financials

Edit Data
Transaction Value£221m
Consideration TypeCash
Capital Owned-
Capital Bid For100%
EV/Sales6x
EV/EBITDA16.93x
Share Price Premium-
One Off Charge-

Tags

Edit

United States

Friendly

Pharmaceuticals

Acquisition

Cross Border

drug development

Majority

Private

Completed

Single Bidder

Private Equity

Synopsis

Edit

Dechra, a global specialist in veterinary pharmaceuticals and related products business, completed the acquisition of Med-Pharmex, a manufacturer of veterinary drugs for the animal health industry, from DW Healthcare Partners, a private equity company, for $260m. "I am delighted that we have completed the acquisition of Med-Pharmex, a company that I have been in dialogue with for a number of years. The US market is highly consolidated, therefore this is a unique opportunity to add several new products to our portfolio, enter the US FAP market and improve the manufacturing footprint for our North American business," Ian Page, Dechra CEO.

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US